First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia.

Tarih
2021
Yazar
Yenerel, Mustafa Nuri
Byrd, John C.
Hillmen, Peter
Ghia, Paolo
Kater, Arnon P.
Chanan-Khan, Asher Alban Akmal
Furman, Richard R.
O'Brien, Susan M.
Illes, Arpad
Kay, Neil E.
Marco, Jose Antonio Garcia
Mato, Anthony R.
Francis, John
Lepretre, Seymour Stephane
Stilgenbauer, Stephan
Robak, Tadeusz
Patel, Priti
Higgins, Kara
Sohoni, Sophia
Jurczak, Wojciech
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/185090
https://doi.org/10.1200/jco.2021.39.15_suppl.7500
Koleksiyonlar